Thomas Hollander
Appearances
- DateMay 18, 2024Recent studies have described the durability of EET for BE-related neoplasia and the risk of neoplastic recurrence after achieving complete eradication of intestinal metaplasia (CE-IM). Current guidelines for endoscopic surveillance intervals post-EET are based on limited evidence…
Presenter
Johns Hopkins HospitalSpeakers
Washington University in St. LouisUniversity of Colorado School of MedicineUniversity of North Carolina at Chapel Hill School of MedicineMayo ClinicNorthwestern UniversityWashington University School of MedicineUniversity of California, Los AngelesUniversity of North CarolinaUCLAUniversity of Colorado
